What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Surgery
His scientific interests lie mostly in Microbiology, Antibacterial agent, Pharmacology, Internal medicine and Staphylococcus aureus.
Ethan Rubinstein combines subjects such as Piperacillin and Actinobacillus with his study of Microbiology.
His Antibacterial agent research is multidisciplinary, incorporating perspectives in Tolerability, Adverse effect, El Niño and Linezolid.
The Internal medicine study combines topics in areas such as Methicillin-resistant Staphylococcus aureus, Surgery, Intensive care, Staphylococcal infections and Vancomycin.
His study in Vancomycin is interdisciplinary in nature, drawing from both Bacteremia and Infective endocarditis.
His Antibiotics study which covers Meningitis that intersects with Intensive care medicine.
His most cited work include:
- Staphylococcus aureus Endocarditis A Consequence of Medical Progress (921 citations)
- Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. (385 citations)
- Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. (265 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Microbiology, Antibiotics, Internal medicine, Antibacterial agent and Surgery.
His research in Microbiology intersects with topics in Bacillus anthracis and Staphylococcus aureus.
In his study, which falls under the umbrella issue of Antibiotics, Antimicrobial and Infective endocarditis is strongly linked to Intensive care medicine.
Methicillin-resistant Staphylococcus aureus is closely connected to Vancomycin in his research, which is encompassed under the umbrella topic of Internal medicine.
Ethan Rubinstein combines subjects such as Ciprofloxacin, Clinical trial, Pediatrics and Pharmacology with his study of Antibacterial agent.
He specializes in Surgery, namely Endocarditis.
He most often published in these fields:
- Microbiology (33.73%)
- Antibiotics (25.00%)
- Internal medicine (26.98%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (26.98%)
- Microbiology (33.73%)
- Vancomycin (11.11%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Microbiology, Vancomycin, Antibiotics and Intensive care medicine.
The various areas that Ethan Rubinstein examines in his Internal medicine study include Telavancin and Surgery.
His Microbiology study combines topics from a wide range of disciplines, such as Ceftazidime and Pharmacology.
His research in Vancomycin focuses on subjects like Bacteremia, which are connected to Retrospective cohort study.
His study looks at the relationship between Antibiotics and topics such as Bacillus anthracis, which overlap with Toxin, Levofloxacin, Spore and Protein synthesis inhibitor.
His Intensive care medicine research integrates issues from Antimicrobial, Organ dysfunction and Cardiothoracic surgery.
Between 2011 and 2021, his most popular works were:
- Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. (242 citations)
- Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. (242 citations)
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli (206 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Surgery
Ethan Rubinstein mainly investigates Pharmacology, Microbiology, Cephalosporin, Ceftazidime and Internal medicine.
His Pharmacology study integrates concerns from other disciplines, such as Aerobic bacteria, Staphylococcus aureus, In vivo and Linezolid.
His study ties his expertise on Avibactam together with the subject of Microbiology.
The study incorporates disciplines such as Bacteroides fragilis, Minimum inhibitory concentration, Anaerobic bacteria and Cephem in addition to Ceftazidime.
Ethan Rubinstein has included themes like Staphylococcal infections and Surgery in his Internal medicine study.
The Surgery study combines topics in areas such as Cohort and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
